1950 |
- Hitachi Chemical Co., Ltd. (as Chemiphar was formerly known) is set up
|
1951 |
- Hatagaya Factory opens in Shibuya-ku, Tokyo
|
1957 |
- Starts importing pharmaceuticals from Italy
- Main office moves to Bunkyo-ku Tokyo
|
1960 |
- Soka Factory opens in Misato City, Saitama Prefecture
|
1969 |
- Nihon Pharmaceutical Industry Co., Ltd. (NPI) becomes an affiliated company
|
1970 |
- Company changes name to Nippon Chemiphar Co., Ltd.
|
1971 |
- Listed on Tokyo Stock Exchange (Second Section)
|
1973 |
- Sets up R&D facility in Soka Factory
|
1975 |
- Head office moved to Chiyoda-ku, Tokyo
|
1976 |
- Listed on Tokyo Stock Exchange (First Section)
- Starts diagnostics business
- Establishes Japan Sopharchim Co., Ltd. (currently an affiliated company)
|
1977 |
- Establishes Ibaraki Factory in Makabe-gun, Ibaraki Prefecture (NPI's current Tsukuba Factory)
|
1983 |
- Establishes Shapro Inc., enters cosmetics and health-food market
|
1986 |
- Safety Research Institute for Chemical Compounds Co., Ltd. becomes a subsidiary
|
1988 |
- Launches Uralyt-U (soluble powder)
|
1993 |
|
1995 |
|
2000 |
- Strengthens focus on generics business
|
2001 |
- Launches DP2000 and Oriton IgE NC
|
2002 |
- Concludes comprehensive business alliance concluded with Ranbaxy Laboratories Limited in India
|
2004 |
- Concludes business alliance with Nihon Chouzai Co., Ltd.
|
2005 |
- PPAR delta agonist and NC-2300 are licensed out to overseas venture companies
- A subsidiary company, NPI, becomes 50:50 joint venture of Chemiphar and Ranbaxy
|
2009 |
- Dissolves the comprehensive business alliance with Ranbaxy. NPI becomes a subsidiary again.
|
2010 |
- NPI becomes a wholly owned Chemiphar subsidiary;.Chemiphar spins off its Ibaraki Factory to NPI.
- Termination of business alliance with Nihon Chouzai Co., Ltd.
|
2012 |
|
2014 |
- New plant at NPI's Tsukuba factory comes on line.
|
2015 |
- Establishes Nippon Chemiphar Vietnam Co., Ltd.
|
2017 |
- NC-VN completes construction of a new plant in Binh Duang Province,Vietnam.
- Establishes West Japan Distribution Center, creating one base each for in East and West Japan.
|
2018 |
- NC-VN Vietnam factory starts export to Japan.
|
2019 |
- Acquires approval for the manufacture and sale of PICOPREP from Ferring Pharmaceuticals Co., Ltd.
|
2020 |
- Launches DropScreen™
- Concluded a license agreement with Delta-Fly Pharma, Inc. for DFP-17729.
- Acquires sales rights for Klaricid from Mylan EPD G.K.
- Delta-Fly Pharma starts phase 1 clinical trials of DFP-17729 for pancreatic cancer.
|
2021 |
|